45 results
8-K
EX-14.1
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
Exhibit 14.1
LARIMAR THERAPEUTICS, INC.
CODE OF BUSINESS CONDUCT AND ETHICS
Effective May 28, 2020
I.Introduction
This Code of Business Conduct … and Ethics (this “Code”)has been adopted by the Board of Directors (the “Board”) of Larimar Therapeutics, Inc. (together with its subsidiaries
8-K
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
by reference into this Item 5.03.
Item 5.05
Amendments to the Registrants Code of Ethics, or Waiver of a Provisions of the Code of Ethics
In connection … with the Merger, the Board adopted a new code of business conduct and ethics (the “Code of Conduct”). The Code of Conduct superseded the Company’s
10-K/A
2015 FY
LRMR
Larimar Therapeutics Inc
29 Apr 16
Annual report (amended)
12:00am
(a) reporting requirements.
Code of Business Conduct and Ethics
We have adopted a Code of Business Conduct and Ethics that applies to all of our … and Ethics is available on our website athttp://ir.zafgen.com/corporate-governance.cfm. A copy of the Code of Business Conduct and Ethics may also
8-K
EX-10.1
f18ctr 09ti26j
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.4
4kk2f4a1r0c6382ox 53
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am